CKD Bio Corp. (063160.KS) KSC
19,900.00
+110(+0.56%)
Currency In KRW
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 111.7B |
| Enterprise Value | 255.23B |
| P/E Ratio | -37.82 |
| PEG Ratio | 0.47 |
| Price/Sales Ratio | 0.68 |
| Price/Book Ratio | 0.86 |
| Enterprise/Revenue | 1.58 |
| Enterprise/EBITDA | 17.97 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
Profitability
| Profit Margin | -0.02 |
| Operating Margin | 0.02 |
Management Effectiveness
| Return On Assets | -0.01 |
| Return On Equity | -0.02 |
Income Statement
| Revenue | 160.07B |
| Revenue/Share | 29,162.06 |
| Gross Profit | 26.1B |
| EBITDA | 19.26B |
| Net Income | -2.89B |
| Diluted EPS | -526.16 |
Balance Sheet
| Total Cash | 1.5B |
| Total Cash/Share | 272.69 |
| Total Debt | 144.96B |
| Total Debt/Equity | 1.14 |
| Current Ratio | 0.9 |
| Book Value Per Share | 23,143.67 |
Price History
| 52-Week Change | -13.85 |
| 52-Week High | 27,650 |
| 52-Week Low | 18,390 |
| Moving Average 50 Days | 19,802.6 |
| Moving Average 200 Days | 21,502.8 |
Statistics
| Average Volume | 28,749 |
| Shares Outstanding | 5.49M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | -0.19 |
| Last Split Factor | 21:20 |
| Last Split Date | December 27, 2019 |
